200,000+ products from a single source!
sales@angenechem.com
158876-82-5 | 5H-Benzo[5,6]cyclohepta[1,2-b]pyridine, 8-chloro-6,11-dihydro-11-[1-[(5-methyl-3-pyridinyl)methyl]-4-piperidinylidene]-
CAS No: 158876-82-5 Catalog No: AG001QYV MDL No:MFCD09039284
Product Description
Catalog Number:
AG001QYV
Chemical Name:
5H-Benzo[5,6]cyclohepta[1,2-b]pyridine, 8-chloro-6,11-dihydro-11-[1-[(5-methyl-3-pyridinyl)methyl]-4-piperidinylidene]-
CAS Number:
158876-82-5
Molecular Formula:
C26H26ClN3
Molecular Weight:
415.9577
MDL Number:
MFCD09039284
IUPAC Name:
13-chloro-2-[1-[(5-methylpyridin-3-yl)methyl]piperidin-4-ylidene]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene
InChI:
InChI=1S/C26H26ClN3/c1-18-13-19(16-28-15-18)17-30-11-8-20(9-12-30)25-24-7-6-23(27)14-22(24)5-4-21-3-2-10-29-26(21)25/h2-3,6-7,10,13-16H,4-5,8-9,11-12,17H2,1H3
InChI Key:
WUZYKBABMWJHDL-UHFFFAOYSA-N
SMILES:
Cc1cncc(c1)CN1CCC(=C2c3ccc(cc3CCc3c2nccc3)Cl)CC1
UNII:
2AE8M83G3E
Properties
Complexity:
609
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
415.182g/mol
Formal Charge:
0
Heavy Atom Count:
30
Hydrogen Bond Acceptor Count:
3
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
415.965g/mol
Monoisotopic Mass:
415.182g/mol
Rotatable Bond Count:
2
Topological Polar Surface Area:
29A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
5.8
Literature
| Title | Journal |
|---|---|
| Loratadine and analogues: discovery and preliminary structure-activity relationship of inhibitors of the amino acid transporter B(0)AT2. | Journal of medicinal chemistry 20141126 |
| Rupatadine 10 mg in the treatment of immediate mosquito-bite allergy. | Journal of the European Academy of Dermatology and Venereology : JEADV 20120701 |
| Histamine and H1-antihistamines: celebrating a century of progress. | The Journal of allergy and clinical immunology 20111201 |
| Rupatadine and levocetirizine in chronic idiopathic urticaria: a comparative study of efficacy and safety. | Journal of drugs in dermatology : JDD 20111201 |
| Fexofenadine-induced urticaria. | Annals of dermatology 20111201 |
| Efficacy of second-generation antihistamines in patients with allergic rhinitis and comorbid asthma. | The Journal of asthma : official journal of the Association for the Care of Asthma 20111101 |
| Fixed drug eruption against rupatadine fumarate. | The Journal of craniofacial surgery 20110901 |
| Rupatadine for the treatment of allergic rhinitis and urticaria. | Expert review of clinical immunology 20110101 |
| Rupatadine improves nasal symptoms, quality of life (ESPRINT-15) and severity in a subanalysis of a cohort of Spanish allergic rhinitis patients. | Journal of investigational allergology & clinical immunology 20110101 |
| Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial. | Journal of asthma and allergy 20110101 |
| In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin. | Journal of inflammation (London, England) 20110101 |
| H1-antihistamine up-dosing in chronic spontaneous urticaria: patients' perspective of effectiveness and side effects--a retrospective survey study. | PloS one 20110101 |
| Olopatadine hydrochloride and rupatadine fumarate in seasonal allergic rhinitis: A comparative study of efficacy and safety. | Journal of pharmacology & pharmacotherapeutics 20110101 |
| Consensus statement on the management of urticaria. | Indian journal of dermatology 20110101 |
| Effect of bilastine upon nasal obstruction. | Journal of investigational allergology & clinical immunology 20110101 |
| Efficacy and tolerability of rupatadine at four times the recommended dose against histamine- and platelet-activating factor-induced flare responses and ex vivo platelet aggregation in healthy males. | The British journal of dermatology 20101201 |
| Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety. | Archives of otolaryngology--head & neck surgery 20100801 |
| Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study. | British journal of clinical pharmacology 20100601 |
| No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a 'thorough QT/QTc study' performed according to ICH guidelines. | British journal of clinical pharmacology 20100401 |
| Prediction and evaluation of protein farnesyltransferase inhibition by commercial drugs. | Journal of medicinal chemistry 20100325 |
| [Rupatadine, oral Rupatall]. | Journal de pharmacie de Belgique 20100301 |
| Stereoselective synthesis of desloratadine derivatives as antagonist of histamine. | Bioorganic & medicinal chemistry 20100215 |
| Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli. | International archives of allergy and immunology 20100101 |
| Rupatadine and heart rhythm disturbances. | Clinical pharmacology and therapeutics 20100101 |
| Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20100101 |
| Rupatadine improves nasal symptoms, airflow and inflammation in patients with persistent allergic rhinitis: a pilot study. | Journal of biological regulators and homeostatic agents 20100101 |
| Structurally diverse metal coordination compounds, bearing imidodiphosphinate and diphosphinoamine ligands, as potential inhibitors of the platelet activating factor. | Bioinorganic chemistry and applications 20100101 |
| Paradoxical exacerbation of chronic urticaria by H1-antihistamines and montelukast. | European annals of allergy and clinical immunology 20091201 |
| Rupatadine: pharmacological profile and its use in the treatment of allergic rhinitis. | Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India 20091201 |
| Treatment of acquired cold urticaria with rupatadine. | Allergy 20090901 |
| The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg. | Journal of the European Academy of Dermatology and Venereology : JEADV 20090901 |
| Pharmacological profile, efficacy and safety of rupatadine in allergic rhinitis. | Primary care respiratory journal : journal of the General Practice Airways Group 20090601 |
| Unsuspected polymorphic metabolism of rupatadine via its primary metabolite, desloratadine. | Primary care respiratory journal : journal of the General Practice Airways Group 20090601 |
| Heart rhythm disturbances associated with rupatadine: a case series from the Spanish and Portuguese pharmacovigilance systems. | Clinical pharmacology and therapeutics 20090501 |
| Torsade de pointes associated with rupatadine. | Revista espanola de cardiologia 20090301 |
| Simultaneous determination of rupatadine and its metabolite desloratadine in human plasma by a sensitive LC-MS/MS method: application to the pharmacokinetic study in healthy Chinese volunteers. | Journal of pharmaceutical and biomedical analysis 20090220 |
| Successful treatment of chronic drug-resistant urticaria with alprazolam. | The Journal of allergy and clinical immunology 20090201 |
| Safety of rupatadine administered over a period of 1 year in the treatment of persistent allergic rhinitis: a multicentre, open-label study in Spain. | Drug safety 20090101 |
| Futura study: evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent allergic rhinitis. | Brazilian journal of otorhinolaryngology 20090101 |
| Reduction of nasal volume after allergen-induced rhinitis in patients treated with rupatadine: a randomized, cross-over, double-blind, placebo-controlled study. | Journal of investigational allergology & clinical immunology 20090101 |
| Ebastine in the light of CONGA recommendations for the development of third-generation antihistamines. | Journal of asthma and allergy 20090101 |
| Determination of rupatadine in pharmaceutical formulations by a validated stability-indicating MEKC method. | Journal of separation science 20080901 |
| Herbex-kid Inhibits Immediate Hypersensitivity Reactions in Mice and Rats. | Evidence-based complementary and alternative medicine : eCAM 20080901 |
| Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study. | Clinical therapeutics 20080901 |
| High performance liquid chromatography-tandem mass spectrometric determination of rupatadine in human plasma and its pharmacokinetics. | Journal of pharmaceutical and biomedical analysis 20080805 |
| A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis. | Allergy 20080701 |
| [Torsades de pointes associated with rupatadine]. | Revista espanola de cardiologia 20080301 |
| Antihistaminic effects of rupatadine and PKPD modelling. | European journal of drug metabolism and pharmacokinetics 20080101 |
| Lack of effects between rupatadine 10 mg and placebo on actual driving performance of healthy volunteers. | Human psychopharmacology 20070701 |
| Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study. | Allergy 20070501 |
| Influence of food on the oral bioavailability of rupatadine tablets in healthy volunteers: a single-dose, randomized, open-label, two-way crossover study. | Clinical therapeutics 20070501 |
| [Protective effect of rupatadine against oleic acid-induced acute lung injury in rabbits]. | Yao xue xue bao = Acta pharmaceutica Sinica 20070301 |
| Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study. | European journal of dermatology : EJD 20070101 |
| Characterization of the de novo biosynthetic enzyme of platelet activating factor, DDT-insensitive cholinephosphotransferase, of human mesangial cells. | Mediators of inflammation 20070101 |
| [Antihistamines in allergic rhinitis]. | Otolaryngologia polska = The Polish otolaryngology 20070101 |
| The proarrhythmic antihistaminic drug terfenadine increases spontaneous calcium release in human atrial myocytes. | European journal of pharmacology 20061228 |
| New antihistamines: a critical view. | Jornal de pediatria 20061101 |
| Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers. | Human psychopharmacology 20060101 |
| Effects of rupatadine vs placebo on allergen-induced symptoms in patients exposed to aeroallergens in the Vienna Challenge Chamber. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20060101 |
| Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study. | Journal of investigational allergology & clinical immunology 20050101 |
| Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study. | Allergy 20040701 |
| Role of histamine and platelet-activating factor in allergic rhinitis. | Journal of physiology and biochemistry 20040601 |
| A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis. | Journal of investigational allergology & clinical immunology 20040101 |
| Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers. | Neuropsychobiology 20040101 |
| Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis. | Drugs of today (Barcelona, Spain : 1998) 20030601 |
| Antihistamines in late-phase clinical development for allergic disease. | Expert opinion on investigational drugs 20020201 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.